Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period

Mammina, Caterina; Calà, Cinzia; Bonura, Celestino; Di Carlo, Paola; Aleo, Aurora; Fasciana, Teresa; Giammanco, Anna
January 2012
Annals of Clinical Microbiology & Antimicrobials;2012, Vol. 11 Issue 1, p17
Academic Journal
Background: The evolving epidemiology of methicillin resistant Staphylococcus aureus (MRSA) is characterized by the emergence of infections caused by non multiresistant MRSA carrying staphylococcal chromosomal cassette (SCC)mec IV or V in the healthcare settings. A molecular epidemiological analysis of non multiresistant MRSA isolates from four acute general hospitals was performed in Palermo, Italy, during a one year period. Methods: For the purpose of the study, MRSA isolates were defined as non multiresistant when they were susceptible to at least three classes of non β-lactam antibiotics. Seventy-five isolates were submitted to antimicrobial susceptibility testing, multilocus sequence typing (MLST) and polymerase chain reaction (PCR) for SCCmec, accessory gene regulator (agr) groups, arginine catabolic mobile element (ACME) and Panton Valentine leukocidin (PVL) toxin genes. For epidemiological typing, Multiple-Locus Variable-Number Tandem Repeat Fingerprinting (MLVF) was performed on all isolates and pulsed field gel electrophoresis (PFGE) on ST8 isolates. Results: Non multiresistant MRSA isolates were isolated from all hospitals. Resistances to ciprofloxacin, macrolides and tetracycline were the most prevalent. MLST attributed 46 isolates with ST22, 13 with ST8, eight with ST1, three with ST50 and three with ST398. SCCmec type IV was found in all isolates. PVL was detected in one ST22 isolate. All isolates tested negative for the ACME element. MLVF identified 31 different patterns, some subtype clusters ranging in size between two and 22 isolates. The closely related PFGE patterns of the ST8 isolates differed from USA300. Conclusions: A polyclonal circulation of non multiresistant MRSA along with blurring of boundaries between healthcare associated (HA)-MRSA and community associated (CA)-MRSA appear to be occurring in our epidemiological setting. A better understanding of spread of MRSA with the support of molecular typing can provide invaluable information in the epidemiological, microbiological and clinical fields.


Related Articles

  • A man with recurrent furunculosis. Embil, John M.; Oliver, Zoe J.; Mulvey, Michael R.; Trepman, Elly // CMAJ: Canadian Medical Association Journal;7/18/2006, Vol. 175 Issue 2, p143 

    The article reports the case of a man who developed a vesicular lesion on his left fifth finger after vacuuming a collection of animal pelts at a historic site. For the next two days, the finger lesion evolved to a furuncle and the thigh lesion had become a necrotizing abscess of purulent...

  • MRSA strain kills two in British hospital.  // Materials Management in Health Care;Feb2007, Vol. 16 Issue 2, p6 

    The article focuses on the effect of methicillin-resistant Staphylococcus aureus (MRSA) to patients in Great Britain hospitals. According to the government's Health Protection Agency (HPA), a strain of MRSA has killed two people and infected nine others at the hospital in Stoke-on-Trent. This...

  • In Vitro Antimicrobial Findings for Fusidic Acid Tested Against Contemporary (2008–2009) Gram-Positive Organisms Collected in the United States. Jones, Ronald N.; Mendes, Rodrigo E.; Sader, Helio S.; Castanheira, Mariana // Clinical Infectious Diseases;2011, Vol. 52 Issue Suppl 7, pS477 

    Fusidic acid has a long history of consistent activity against staphylococcal pathogens including methicillin-resistant Staphylococcus aureus (MRSA). Fusidic acid (CEM-102) was susceptibility tested against a surveillance study collection of 12,707 Gram-positive pathogens (2008–2009) from...

  • The Safety Record of Fusidic Acid in Non-US Markets: A Focus on Skin Infections. Kraus, Carl N.; Burnstead, Barry W. // Clinical Infectious Diseases;2011, Vol. 52 Issue Suppl 7, pS527 

    Fusidic acid has been in clinical use outside the United States (US) since 1962 for skin infections, including methicillin-resistant Staphylococcus aureus (MRSA). Non-US labeling reflects safety concerns related to gastrointestinal, allergic, hematologic, and neurologic adverse events. We sought...

  • Comparative analysis of MRSA strains isolated from cases of mupirocin ointment treatment in which eradication was successful and in which eradication failed. Ogura, Masamichi; Yano, Hisako; Sato, Mikinori; Nakamura, Atsushi; Wakimoto, Yukio; Ohkusu, Kiyofumi; Ezaki, Takayuki // Journal of Infection & Chemotherapy;Apr2013, Vol. 19 Issue 2, p196 

    Nasal decolonization in methicillin-resistant Staphylococcus aureus (MRSA) carriers using mupirocin (MUP) is a strategy that complements barrier precautions and contact isolation. However, eradication failure cases have been observed despite isolates being susceptible to MUP. This would suggest...

  • Prevalence and Antimicrobial Susceptibility Pattern of Methicillin Resistance Staphylococcus in a Sudanese Surgical Ward. Kheder, Salah Ibrahim; Ali, Nagla A.; Fathelrahman, Ahmed Ibrahim // Pharmacology & Pharmacy;Jan2012, Vol. 3 Issue 1, p103 

    Background: Methicillin-resistant Staphylococcus aureus (MRSA) is important nosocomial pathogen. Aim: In this paper, we determined the prevalence and the antibiotic susceptibility pattern of (MRSA) in a Sudanese surgical ward. Method: A total of 200 post-operative surgical specimens were...

  • STIFLE STAPH. Jackson, Dwayne // Joe Weider's Muscle & Fitness;Mar2008, Vol. 69 Issue 3, p264 

    The article offers information on methicillin-resistant Staphylococcus aureus (MRSA). Staphylococcus aureus belongs to a group of bacteria known simply as staph, one of the most frequent causes of skin infections in the U.S. Most of the time, skin infections caused by staph are minor and result...

  • MRSA: superbug expected to drive growth of niche market.  // PharmaWatch: Monthly Review;Feb2007, Vol. 6 Issue 2, p21 

    The article focuses on the proliferation of the community-acquired methicillin resistant Staphylococcus aureus (MRSA) in Great Britain. The incidence of MRSA is still increasing, making the niche market a highly interesting target for drug developers. Report reveals that the death of a healthy...

  • Fight "Superbugs" This Winter. Schetchikova, Nataliya // ACA News (American Chiropractic Association);Jan2008, Vol. 4 Issue 1, p14 

    The article offers tips for curbing antibiotic resistance and reducing the likelihood of falling victim to methicillin-resistant Staphylococcus aureus (MRSA). Antibiotic resistance is a natural process in the evolution of bacteria. Some bacteria can cause illnesses that are usually treated with...

  • Infection control in the community - do we have a problem? Wrobel, Bernadine; Maryon, Beth // Journal of Community Nursing;Jun2006, Vol. 20 Issue 6, p16 

    Provides information on a study which investigated the incidence of methicillin resistant staphylococcus aureus (MRSA) infection in a suburb of London, England. Factors considered in the assessment process; Main routes of infection; Factors contributing to MRSA incidence.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics